This is the first time that over-the-counter bladder medication has been available without a prescription.
Pharmacists, general practitioners, other health professionals, the general public, and women are encouraged to participate in reclassification counseling.
Aquiette 2.5 mg tablets contain oxibutin hydrochloride արկ considered for reclassification. These pills are used to treat women with milder symptoms of an overactive bladder that are not controlled by bladder training alone. Symptoms include the need to urinate at least eight times a day, more than once a night, sometimes resulting in accidental discharge.
If the answer is yes և a decision is made to reclassify this treatment, pharmacists will have access to the training materials և a checklist that will allow them to identify women who can safely supply this medicine.
Dr. Laura Squire, MHRA’s Chief Health Officer for Healthcare Quality and Accessibility, said:
“We encourage women health professionals who have experience in using this vital treatment to get involved in counseling and to make your views heard. Each answer we receive will help us to have a better idea of whether people think this rearrangement will work.
“Living with an overactive bladder can be very difficult, so it is very important to hear from as many people as possible, from groups of women.
“We are fully committed to improving access to medicines where it is safe.”
The Minister of Women’s Health Maria Caulfield said.
“When it comes to sensitive issues such as bladder control, talking to a doctor can be a barrier for some women seeking help. Aquiette reclassification will allow women to use vital medicines without the need for a prescription.
“Facilitating access to health care for women is essential to making them live better and reducing the gender gap.
“I encourage all women who have experienced these symptoms to make their voices heard by responding to the call of evidence.”
Commission on Human Drugs (CHM) Consulted ացվել informed that it is safe for these products to be available as a pharmacy (P) medicine.
Notes to the editor:
- Advice page:
- Medicines և Health Products Regulatory Agency (MHRA) is responsible for regulating all medicines և medical devices in the United Kingdom, ensuring that they work, are acceptable and safe. All our work is based on sound, fact-based judgments to ensure that the benefits justify any risk.
- MHRA is an executive agency Department of Health and Social Protection.
- Commission on Human Drugs (CHM) Advises ministers on the safety and effectiveness of medicines.
Share your thoughts on making overactive bladder treatment available to women without the need for a prescription
SourceShare your thoughts on making overactive bladder treatment available to women without the need for a prescription